Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03770858 · ClinicalTrials.gov registry record
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 23
- Enrollment target
NCT03770858: Completed study, sponsored by Northwestern University.
NCT03770858 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03770858 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Pilot study of flexible and wearable sensor to monitor nocturnal scratching behavior
Interventions
- DRUG Crisaborole
- DEVICE Scratch sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2022-08-24 |
What the finished NCT03770858 record still lists
NCT03770858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Crisaborole is the first listed.
NCT03770858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03770858 about?
NCT03770858 is a clinical study titled "Wearable Skin Sensors to Assess Nocturnal Scratch Behavior". Pilot study of flexible and wearable sensor to monitor nocturnal scratching behavior
What is the current status of trial NCT03770858?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-04-18. Estimated completion is 2022-08-24.
What interventions are being tested in trial NCT03770858?
The interventions under investigation include: Crisaborole (DRUG), Scratch sensor (DEVICE).
Who is sponsoring clinical trial NCT03770858?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI